Search Results
Jul 24, 2026, 00:44 ET Fractal posts 20% revenue growth and 92% net income growth in Q1 FY27
Qure.ai, a global healthcare AI leader focused on the rapid identification and management of tuberculosis, lung cancer, and stroke (or critical health conditions). Fractal's suite of businesses consists of Asper.ai (a
More news about: Fractal Analytics Limited
Jul 24, 2026, 00:38 ET Fractal posts 20% revenue growth and 92% net income growth in Q1 FY27
Qure.ai, a global healthcare AI leader focused on the rapid identification and management of tuberculosis, lung cancer, and stroke (or critical health conditions). Fractal's suite of businesses consists of Asper.ai (a
More news about: Fractal Analytics Limited
Jul 24, 2026, 00:24 ET Fractal posts 20% revenue growth and 92% net income growth in Q1 FY27
Qure.ai, a global healthcare AI leader focused on the rapid identification and management of tuberculosis, lung cancer, and stroke (or critical health conditions). Fractal's suite of businesses consists of Asper.ai (a
More news about: Fractal Analytics Limited
Jul 23, 2026, 21:00 ET ArkBio Completes all Cohort Dosing in Australian Phase I Trial with Influenza AFC Drug AK0406
ArkBioArkBio is a commercial-stage biotechnology company focused on the discovery and development of innovative therapeutics for respiratory/lung and pediatric diseases. Founded in 2014, the company has established proprietary technology platforms and a differentiated R&D pipeline through
More news about: Shanghai Ark Biopharmaceutical Co., Ltd.
Jul 23, 2026, 21:00 ET ArkBio Completes all Cohort Dosing in Australian Phase I Trial with Influenza AFC Drug AK0406
ArkBioArkBio is a commercial-stage biotechnology company focused on the discovery and development of innovative therapeutics for respiratory/lung and pediatric diseases. Founded in 2014, the company has established proprietary technology platforms and a differentiated R&D pipeline through
More news about: Shanghai Ark Biopharmaceutical Co., Ltd.
Jul 23, 2026, 10:31 ET ALK Inhibitors Market Set for Transformational Growth at a CAGR of 4% During the Forecast Period (2026-2036) Backed by Next-Generation Targeted Therapies| DelveInsight
Non-Small Cell Lung Cancer MarketNon-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding
More news about: DelveInsight Business Research, LLP
Jul 23, 2026, 09:00 ET HOPPR Brings AI Foundation Models to Chest CT, Expanding Developer Access Across Its Growing Medical Imaging Portfolio
expert services that meet development teams wherever they are.Generates descriptive imaging language from chest CT, including lung nodule characterization and aortic measurements, covering the range of findings in a routine chest CT study.Trained on a large proprietary
More news about: HOPPR
Jul 23, 2026, 07:42 ET AprilAire Announces Homeowner Guidelines for Maintaining Indoor Air Quality During Wildfire Smoke Events
travel deep into the lungs and may even enter the bloodstream.Research has linked wildfire smoke exposure to respiratory irritation, reduced lung function, and other health concerns, particularly for vulnerable populations including children, older adults, pregnant women, and individuals with
More news about: AprilAire
Jul 23, 2026, 07:30 ET Maverix Names Carla Jung Chief Executive Officer to Lead Next Phase of Growth
MedicalMaverix Medical aims to improve and save lives by revolutionizing the diagnosis and treatment of lung cancer. We seek to bring cutting-edge technologies to lung cancer care, empowering clinicians to diagnose lung cancer earlier and treat patients more effectively.Media Contact:Will Kynes,
More news about: Maverix Medical
Jul 23, 2026, 07:00 ET Insmed to Host Second-Quarter 2026 Financial Results Conference Call on Thursday, August 6, 2026
advancing a diverse portfolio of approved and mid- to late-stage investigational medicines—including two approved therapies to treat chronic, debilitating lung diseases— as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's commercial portfolio and
More news about: Insmed Incorporated
Jul 23, 2026, 07:00 ET Cigna Healthcare Expands AI-Enabled Personalized Support to Help More Customers Access Care Earlier and Improve Affordability
avoidable inpatient stays among customers who engage early with care management supportEarlier identification of likely breast, colorectal, and lung cancer diagnoses by approximately 55, 46, and 37 days, respectively72% of customers achieving clinically meaningful improvement
More news about: Cigna Healthcare
Jul 22, 2026, 13:58 ET Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer
relapsed small-cell lung cancer from licensor Hansoh Pharma Inc.About JideytroJideytro is a kinase inhibitor that is FDA approved for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) who received
More news about: GSK plc
Jul 22, 2026, 13:16 ET MouthPad, the first-ever tongue trackpad, launches to the public alongside new wearable, Vox
is greatly reduced.Particularly in the voice AI era, the team hopes Vox will help ensure equitable access to dictation for people with limited lung function, speech impediments, or hand impairments, including current MouthPad users who rely on speech-to-text for typing.All proceeds from the
More news about: Augmental
Jul 22, 2026, 07:03 ET Tikva Allocell Closes $8 Million Series A Financing to Advance Engineered EBV-Specific T-Cell Therapy for Solid Tumors
Singapore and the United States.TAVST01 targets B7-H3, a protein expressed across a broad range of difficult-to-treat solid tumors, including lung, breast, prostate, pancreatic, and pediatric cancers. Unlike conventional donor-derived cell therapies, which a patient's immune system often clears
More news about: Tikva Allocell
Jul 22, 2026, 07:00 ET Cizzle Bio Launches CIZ1B Biomarker Blood Test for Early Lung Cancer
Texas-based Cizzle Bio, Inc., a biotechnology company advancing biomarker blood tests for early lung and gastric cancers, today announced the commercial launch of its proprietary CIZ1B Biomarker Blood Test for Lung Cancer for licensed health care providers in Dallas-Fort Worth and San Antonio.
More news about: Cizzle Bio
Jul 22, 2026, 07:00 ET John Overton High School student receives Humane Science Award from National Anti-Vivisection Society
Nunnery's project, "Regulation of the PPARγ Pathway in Lung Cancer," utilized both traditional cell cultures and advanced three-dimensional human cell-based models to study lung cancer. Investigating therapeutic compounds within these human-derived models allowed Nunnery
More news about: National Anti-Vivisection Society (NAVS)
Jul 22, 2026, 05:01 ET American Lung Association Empowers Schools to Protect Student and Staff Health
Lung.org/casc.About the American Lung AssociationThe American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic
More news about: American Lung Association
Jul 21, 2026, 16:05 ET TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026
Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the second quarter 2026 after market close on Tuesday, August 4,
More news about: TransMedics Group, Inc.
Jul 21, 2026, 10:57 ET In HelloNation, Expert Veterinarian Dr. Kristian Shriver Shares Warning Signs That Your Pet May Need Veterinary Care
scheduling a veterinary wellness exam on a regular basis. A veterinary wellness exam gives veterinarians the opportunity to assess weight, heart and lung function, mobility, dental health, and other important indicators of overall wellness while establishing a medical history that makes subtle changes
More news about: HelloNation
Jul 21, 2026, 08:30 ET The Second Battlefield for Solid Tumor CAR-T: A Global Race in the Intracranial Arena -- Who Is Leading?
CAR-T First-in-Human Data to Debut at the World Conference on Lung CancerBEIJING, July 21, 2026 /PRNewswire/ -- Recently, the 2026 World Conference on Lung Cancer (WCLC) released a set of abstracts that drew notable industry
More news about: T-MAXIMUM PHARMACEUTICAL
Jul 21, 2026, 07:00 ET Altesa BioSciences Welcomes Seasoned Biotech Leader Brett Haumann, MBBCh, MBA as Chief Executive Officer
resource utilization, and lung function.About Altesa BioSciences, Inc.Altesa BioSciences is a clinical-stage pharmaceutical company led by global experts in respiratory medicine and infectious diseases. Altesa is dedicated to improving the lives of people with chronic lung diseases,
More news about: Altesa Biosciences Inc.
Jul 21, 2026, 05:11 ET Mega Matrix Inc. Announces Sports Comeback Drama "From NBA Dropout to Tennis Ace" Now Streaming on FlexTV
takes Ricky's life and ends Kevin's basketball future overnight. After losing his full scholarship, Kevin must also find a way to pay for his mother's lung cancer treatment, all while wealthy rival Bryce publicly humiliates him online.At his lowest point, struggling tennis coach Dale offers Kevin
More news about: Mega Matrix Inc.
Jul 21, 2026, 01:01 ET Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy
The company's pipeline includes programs targeting PRMT5 and SOS1/RAS-pathway biology, with an initial development focus in solid tumors including lung, pancreatic, ovarian, and CNS-relevant cancers. Kaveri is focused on biomarker-driven clinical development, regulatory execution, rational combination
More news about: Lupin Pharmaceuticals, Inc.
Jul 21, 2026, 01:00 ET TMGM đồng hành cùng Chelsea FC trong chuyến du đấu trước mùa giải 2026 tại Châu Á - Thái Bình Dương
bộ triển khai nhiều hoạt động trong khu vực, trong đó có sự kiện dành cho người hâm mộ The Famous CFC tại Bangkok. Thương hiệu TMGM cũng xuất hiện ở lưng áo đấu của các cầu thủ trong chiến dịch FA Cup 2025/26.Trong suốt chuyến du đấu, TMGM sẽ hiện diện tại các địa điểm thi đấu và
More news about: TMGM
Jul 20, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Công Bố Lượng ETH Nắm Giữ Đạt 5,78 Triệu Token, Đưa Tổng Tài Sản Tiền Mã Hóa và Tiền Mặt Lên Mức 11,5 Tỷ USD
liên kết tại đây) cho tháng 7 năm 2026. Tiêu đề của Thông Điệp này là "ETH chính là liều thuốc giải cho Thung Lũng Kỳ Lạ của Sự Giàu Có."Vào đầu năm 2026, Bitmine đã ra mắt MAVAN (Made in American VAlidator Network) — nền tảng staking chuyên biệt dành cho
More news about: Bitmine Immersion Technologies, Inc.